Molecular photoswitch improves visual acuity in retinitis pigmentosa
Drug Discovery World
NOVEMBER 10, 2023
Although the study was not powered to primarily assess efficacy, the kinetic visual field (Goldmann perimetry) increased significantly from baseline at days seven and 14 post treatment. KIO-301 was safe and well tolerated with no ocular and non-ocular serious adverse events, nor any signs of retinal inflammation.
Let's personalize your content